EP Patent

EP0906307B1 — Substituted imidazoles having cytokine inhibitory activity

Assigned to Merck and Co Inc · Expires 2005-04-27 · 21y expired

What this patent protects

Compounds represented by formula I: <IMAGE> I are disclosed. AR represents an aromatic group containing 6-10 atoms; and <IMAGE> represents a 4 to 10 membered non-aromatic heterocycle containing at least one N atom, and optionally containing 1-2 additional N a…

USPTO Abstract

Compounds represented by formula I: <IMAGE> I are disclosed. AR represents an aromatic group containing 6-10 atoms; and <IMAGE> represents a 4 to 10 membered non-aromatic heterocycle containing at least one N atom, and optionally containing 1-2 additional N atoms and 0-1 O or S atom. A pharmaceutical composition is also included. Methods of treating cancer and cytokine mediated diseases are also included.

Drugs covered by this patent

Patent Metadata

Patent number
EP0906307B1
Jurisdiction
EP
Classification
—
Expires
2005-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.